Value-based insurance design in oncology

Lancet Oncol. 2011 Apr;12(4):321-3. doi: 10.1016/S1470-2045(11)70043-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / economics*
  • Cost Sharing / economics*
  • Cost-Benefit Analysis
  • Humans
  • Insurance, Health, Reimbursement / economics*

Substances

  • Antineoplastic Agents